Jazz Pharmaceuticals Plc Forecast, price target & analysts
Jazz Pharmaceuticals Plc Target price 2025 - Analyst rating & recommendation
Jazz Pharmaceuticals Plc Classifications & Recommendation:
Jazz Pharmaceuticals Plc Price Target
| Target Price | $186.66 |
| Price | $106.90 |
| Potential |
74.61%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target Jazz Pharmaceuticals Plc 2026 .
The average Jazz Pharmaceuticals Plc target price is $186.66.
This is
74.61%
register free of charge
$241.50
125.91%
register free of charge
$148.47
38.89%
register free of charge
|
|
| A rating was issued by 24 analysts: 21 Analysts recommend Jazz Pharmaceuticals Plc to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Jazz Pharmaceuticals Plc stock has an average upside potential 2026 of
74.61%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 4.07 | 4.32 |
| 6.12% | 6.05% | |
| EBITDA Margin | 33.27% | 17.94% |
| 0.84% | 46.09% | |
| Net Margin | 13.77% | 7.20% |
| 27.23% | 47.70% |
20 Analysts have issued a sales forecast Jazz Pharmaceuticals Plc 2025 . The average Jazz Pharmaceuticals Plc sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Jazz Pharmaceuticals Plc EBITDA forecast 2025. The average Jazz Pharmaceuticals Plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Jazz Pharmaceuticals Plc Analysts have issued a net profit forecast 2025. The average Jazz Pharmaceuticals Plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 8.48 | 5.04 |
| 47.48% | 40.57% | |
| P/E | 21.20 | |
| EV/Sales | 2.15 |
20 Analysts have issued a Jazz Pharmaceuticals Plc forecast for earnings per share. The average Jazz Pharmaceuticals Plc EPS is
This results in the following potential growth metrics and future valuations:
Jazz Pharmaceuticals Plc...
Current Jazz Pharmaceuticals Plc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 03 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 07 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 07 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | May 07 2025 |
| Needham |
Locked
➜
Locked
|
Locked | May 07 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Jun 11 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 03 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
May 07 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 07 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
